The AHA Saturday sent the Health Resources and Services Administration a letter requesting clarifications for several elements of the COVID-19 Uninsured Program.

Beginning May 6, 2020, providers may submit claims through the program for uninsured patients’ COVID-19 testing and treatment. The AHA urged HRSA to clarify coding guidance to ensure consistency with International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) guidelines, as well as reimbursement rates and timing for submitting certain claims. 

Read the AHA Special Bulletin for more details.

Related News Articles

Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
A CDC study  released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…